Affiliation:
1. Department of Health Statistics Second Military Medical University Shanghai China
2. Mount Sinai St. Luke's and West Medical Center New York NY
3. Department of Cardiology Shanghai Changning District Central Hospital Shanghai China
4. Clinical Epidemiology and Biostatistics School of Medical Sciences Örebro University Örebro Sweden
5. Tongji University School of Medicine Shanghai China
Abstract
Background
The aim of the study is to compare in‐hospital outcomes of acute ST‐segment‐elevation myocardial infarction (STEMI) between China and the United States.
Methods and Results
Urban teaching hospitals were queried for adult patients with a primary diagnosis of
acute STEMI
during 2007–2010. The primary outcome was in‐hospital mortality, and the secondary outcome was length of stay. Multivariable analyses adjusting for potential confounders were conducted for comparison between countries. Subgroup analysis was performed in
acute STEMI
patients receiving revascularization. In total, 32 228 patients in China and 76 117 patients in the United States were included. Overall in‐hospital mortality was 8.23% in China and 7.96% in the United States (
P
<0.001). Multivariable analyses revealed that the 2 countries had similar overall in‐hospital mortality (odds ratio, 0.97; 95%
CI
, 0.87–1.09;
P
=0.59), whereas China had lower 3‐day mortality (odds ratio, 0.78; 95%
CI
, 0.70–0.89;
P
<0.001). In patients receiving primary percutaneous coronary interventions, Chinese hospitals had significant higher overall mortality (odds ratio, 2.39; 95%
CI
, 1.85–3.07;
P
<0.001) and 3‐day mortality (odds ratio, 2.39; 95%
CI
, 1.78–3.20;
P
<0.001). For total acute
STEMI
patients, acute
STEMI
patients receiving percutaneous coronary intervention and coronary artery bypass grafting, median length of stay in China and the United States were 10 versus 3, 9 versus 3, and 25 versus 9 days, respectively (all
P
<0.001).
Conclusions
Overall in‐hospital mortality in acute
STEMI
patients was comparable among urban teaching hospitals between China and the United States during 2007–2010. In addition, 3‐day mortality was lower in China. However, worse outcomes in patients undergoing early revascularization and longer length of stay in China need to be given more attention.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献